NEURAXIS, INC. Operating Cash Flow
NEURAXIS, INC. (NRXS) reported Operating Cash Flow of -$2.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- NEURAXIS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.03M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.23M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.93M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.43M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$6.43M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$6.10M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$6.69M.
- NEURAXIS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$2.30M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$2.26M 10-Q · filed 2026-08-11 | -$4.19M derived: sum of 3 quarters · filed 2026-08-11 | -$5.62M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$1.23M 10-Q · filed 2026-05-12 | -$3.16M derived: sum of 2 quarters · filed 2026-05-12 | -$4.59M derived: sum of 3 quarters · filed 2026-05-12 | -$6.06M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$3.36M derived: sum of 2 quarters · filed 2026-03-19 | -$4.83M derived: sum of 3 quarters · filed 2026-08-11 | -$6.43M 10-K · filed 2026-03-19 |
| 2025-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.90M derived: sum of 2 quarters · filed 2026-08-11 | -$4.50M 10-Q · filed 2025-11-10 | -$6.26M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$3.07M 10-Q · filed 2026-08-11 | -$4.83M derived: sum of 3 quarters · filed 2026-08-11 | -$6.22M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-12 | -$3.36M derived: sum of 2 quarters · filed 2026-05-12 | -$4.75M derived: sum of 3 quarters · filed 2026-05-12 | -$6.37M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$3.15M derived: sum of 2 quarters · filed 2026-03-19 | -$4.77M derived: sum of 3 quarters · filed 2026-03-19 | -$6.10M 10-K · filed 2026-03-19 |
| 2024-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.01M derived: sum of 2 quarters · filed 2025-11-10 | -$4.34M 10-Q · filed 2025-11-10 | -$6.97M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.95M 10-Q · filed 2025-08-12 | -$5.58M derived: sum of 3 quarters · filed 2025-08-12 | -$8.39M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$1.33M 10-Q · filed 2025-05-12 | -$3.96M derived: sum of 2 quarters · filed 2025-05-12 | -$6.78M derived: sum of 3 quarters · filed 2025-05-12 | -$7.40M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$5.45M derived: sum of 2 quarters · filed 2025-03-20 | -$6.07M derived: sum of 3 quarters · filed 2025-03-20 | -$6.69M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.44M derived: sum of 2 quarters · filed 2024-11-12 | -$4.06M 10-Q · filed 2024-11-12 | -$4.28M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$625.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.25M 10-Q · filed 2024-08-09 | -$1.46M derived: sum of 3 quarters · filed 2024-08-09 | -$2.37M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$622.91K 10-Q · filed 2024-05-20 | -$837.23K derived: sum of 2 quarters · filed 2024-05-20 | -$1.75M derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | -$214.31K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$1.13M derived: sum of 2 quarters · filed 2024-04-16 | -$2.30M 10-K · filed 2024-04-16 | |
| 2022-09-30 | -$911.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | -$2.08M 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | -$1.17M 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |